Publikation: siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
The targeted inhibition of antiapoptotic factors in tumour cells may provide a rational approach towards the development of novel anticancer therapies. Using human papillomavirus (HPV)-transformed cells as a model system, we investigated if RNA interference (RNAi)-mediated gene silencing can be employed in order to overcome the apoptosis resistance of cancer cells. We found that both vector-borne and synthetic small interfering (si)RNAs, specifically directed against the antiapoptotic HPV E6 oncogene, restored dormant tumour suppressor pathways in HPV-positive cancer cells that are otherwise inactive in the presence of E6. This ultimately resulted in massive apoptotic cell death, selectively in HPV-positive tumour cells. These findings show that RNAi provides a powerful molecular strategy to inactivate intracellular E6 function efficiently. Moreover, they define E6 as a most promising therapeutic target to eliminate HPV-positive tumour cells specifically by RNAi. Thus, by sequence-specific targeting of antiapoptotic genes, siRNAs may be developed into novel therapeutics that can efficiently correct the apoptosis deficiency of cancer cells.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
BUTZ, Karin, Tutik RISTRIANI, Arnd HENGSTERMANN, Claudia DENK, Martin SCHEFFNER, Felix HOPPE-SEYLER, 2003. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. In: Oncogene. 2003, 22(38), pp. 5938-5945. ISSN 0950-9232. eISSN 1476-5594. Available under: doi: 10.1038/sj.onc.1206894BibTex
@article{Butz2003-09-04siRNA-42200, year={2003}, doi={10.1038/sj.onc.1206894}, title={siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells}, number={38}, volume={22}, issn={0950-9232}, journal={Oncogene}, pages={5938--5945}, author={Butz, Karin and Ristriani, Tutik and Hengstermann, Arnd and Denk, Claudia and Scheffner, Martin and Hoppe-Seyler, Felix} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/42200"> <dc:creator>Ristriani, Tutik</dc:creator> <dc:contributor>Denk, Claudia</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-04-28T13:35:00Z</dc:date> <dc:language>eng</dc:language> <dc:contributor>Hengstermann, Arnd</dc:contributor> <dcterms:issued>2003-09-04</dcterms:issued> <dc:creator>Hengstermann, Arnd</dc:creator> <dc:contributor>Butz, Karin</dc:contributor> <dc:contributor>Hoppe-Seyler, Felix</dc:contributor> <dc:contributor>Ristriani, Tutik</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2018-04-28T13:35:00Z</dcterms:available> <dc:creator>Butz, Karin</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:abstract xml:lang="eng">The targeted inhibition of antiapoptotic factors in tumour cells may provide a rational approach towards the development of novel anticancer therapies. Using human papillomavirus (HPV)-transformed cells as a model system, we investigated if RNA interference (RNAi)-mediated gene silencing can be employed in order to overcome the apoptosis resistance of cancer cells. We found that both vector-borne and synthetic small interfering (si)RNAs, specifically directed against the antiapoptotic HPV E6 oncogene, restored dormant tumour suppressor pathways in HPV-positive cancer cells that are otherwise inactive in the presence of E6. This ultimately resulted in massive apoptotic cell death, selectively in HPV-positive tumour cells. These findings show that RNAi provides a powerful molecular strategy to inactivate intracellular E6 function efficiently. Moreover, they define E6 as a most promising therapeutic target to eliminate HPV-positive tumour cells specifically by RNAi. Thus, by sequence-specific targeting of antiapoptotic genes, siRNAs may be developed into novel therapeutics that can efficiently correct the apoptosis deficiency of cancer cells.</dcterms:abstract> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/42200"/> <dc:contributor>Scheffner, Martin</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:creator>Hoppe-Seyler, Felix</dc:creator> <dcterms:title>siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells</dcterms:title> <dc:creator>Denk, Claudia</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:creator>Scheffner, Martin</dc:creator> </rdf:Description> </rdf:RDF>